TY - JOUR
T1 - Transgastric pancreaticogastric anastomosis
T2 - An alternative operative approach for middle pancreatectomy
AU - Lafemina, Jennifer
AU - Vagefi, Parsia A.
AU - Warshaw, Andrew L.
AU - Castillo, Carlos Fernández Del
N1 - Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.
PY - 2010/5
Y1 - 2010/5
N2 - Objective: To determine short-term outcomes following middle pancreatectomy with transgastric pancreaticogastric anastomosis. Design, Setting, and Patients: A retrospective analysis of 23 patients who underwent middle pancreatectomy with transgastric pancreaticogastric anastomosis at the Massachusetts General Hospital, Boston, from June 22, 2005, through April 29, 2009. Main Outcome Measures: Indications for procedure, operative time, length of stay, morbidity, mortality, and need for readmission, antibiotics, reoperation, additional procedures, or transfusion. Results: The mean age of 15 women and 8 men who underwent middle pancreatectomy with transgastric pancreaticogastric anastomosis was 55.0 years. The median follow-up time was 12.9 months. The most commonly resected tumors were intraductal papillary mucinous neoplasms (n=9), serous cystadenomas (n=5), and neuroendocrine tumors (n=4). The mean (SD) operative time was 191 (39) minutes. No patients required intraoperative transfusion. The median hospital stay was 5 days. The mostcommoncomplications were pancreatic fistula (n=6), intra-abdominal abscess (n=4), and superficial skin infection (n=4). Three patients had splenic artery pseudoaneurysms. Seven patients required readmission; 2 required reoperation. No patients developed postoperative new or worsening endocrine or exocrine insufficiency. There were no deaths. Conclusions: Middle pancreatectomy with transgastric pancreaticogastric anastomosis offers a safe alternative to the traditional Roux-en-y pancreaticojejunostomy and may be technically simpler.
AB - Objective: To determine short-term outcomes following middle pancreatectomy with transgastric pancreaticogastric anastomosis. Design, Setting, and Patients: A retrospective analysis of 23 patients who underwent middle pancreatectomy with transgastric pancreaticogastric anastomosis at the Massachusetts General Hospital, Boston, from June 22, 2005, through April 29, 2009. Main Outcome Measures: Indications for procedure, operative time, length of stay, morbidity, mortality, and need for readmission, antibiotics, reoperation, additional procedures, or transfusion. Results: The mean age of 15 women and 8 men who underwent middle pancreatectomy with transgastric pancreaticogastric anastomosis was 55.0 years. The median follow-up time was 12.9 months. The most commonly resected tumors were intraductal papillary mucinous neoplasms (n=9), serous cystadenomas (n=5), and neuroendocrine tumors (n=4). The mean (SD) operative time was 191 (39) minutes. No patients required intraoperative transfusion. The median hospital stay was 5 days. The mostcommoncomplications were pancreatic fistula (n=6), intra-abdominal abscess (n=4), and superficial skin infection (n=4). Three patients had splenic artery pseudoaneurysms. Seven patients required readmission; 2 required reoperation. No patients developed postoperative new or worsening endocrine or exocrine insufficiency. There were no deaths. Conclusions: Middle pancreatectomy with transgastric pancreaticogastric anastomosis offers a safe alternative to the traditional Roux-en-y pancreaticojejunostomy and may be technically simpler.
UR - http://www.scopus.com/inward/record.url?scp=77952417669&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952417669&partnerID=8YFLogxK
U2 - 10.1001/archsurg.2010.61
DO - 10.1001/archsurg.2010.61
M3 - Article
C2 - 20479347
AN - SCOPUS:77952417669
SN - 0004-0010
VL - 145
SP - 476
EP - 481
JO - Archives of Surgery
JF - Archives of Surgery
IS - 5
ER -